Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

AQB vs ABP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AQB Captures Overall Composite Edge (44.6 HOLD vs 44.4 HOLD), While ABP Leads 3–1 on Growth & Valuation Pillars

AQB Overall Winner 6-Pillar Tally: AQB 1 – 3 ABP (2 Tie) Matrix Metrics: AQB 4 – 1 ABP

As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Abpro Holdings, Inc (ABP) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.4/100 HOLD) after splitting the core matrix 4–1 (led by Growth & Scale), while ABP wins 3–1 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus ABP at $0.52 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. ABP 44.4/100 HOLD) and 0.93β · 117% Vol risk profile, whereas ABP leads top-line expansion (-100.0% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile ABP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AQB vs ABP
AQB NASDAQ Head-to-Head Winner
AquaBounty Technologies, Inc.
Fishing, Hunting And Trapping
$0.82
+2.01% 1D
Market Cap $9.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.93β · 117% Vol
Unified Composite Score
44.6 / 100 HOLD
Tech 33.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 37
RSI-14: 37.5 · SMA20: $1.04 · SMA50: $1.03
ABP NASDAQ
Abpro Holdings, Inc Common Stock
Biological Products, (No Disgnostic Substances)
$0.52
-34.76% 1D
Market Cap $2.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.33β · 258% Vol
Unified Composite Score
44.4 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -36.3%), weak momentum, RSI 22
RSI-14: 22.2 · SMA20: $1.51 · SMA50: $3.29

6-Pillar Scorecard Institutional Category Breakdown (AQB 1 – 3 ABP)

Columns: Metric · AQB · ABP
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale AQB
Revenue Growth (YoY) -93.5% -100.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A N/A
Market Cap $9.7M $2.2M
3. Profitability & Quality ABP
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -68.9% 0.0%
4. Balance Sheet & Cash Flow ABP
Cash Generation (TTM) -$7.2M N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $0.19 Book/Sh · -68.9% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABP
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Farm Products Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AQB (4) vs ABP (1)
Institutional Metric AQB ABP Criterion Row Edge
Market Capitalization
Scale
$9.7M $2.2M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-93.5% -100.0% Higher Growth AQB
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-68.9% 0.0% Higher ROE ABP
52-Week Range Position
Momentum
11% ($1–$2) 0% ($1–$32) Stronger Trend AQB
Beta / 30D Volatility
Risk Regime
0.93β · 117% Vol 2.33β · 258% Vol Lower Realized Risk AQB
Unified Institutional Score
Composite Signal
44.6 / 100 (HOLD) 44.4 / 100 (HOLD) Higher Composite AQB
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.2M ($0.19 Book/Sh · -68.9% ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AQB +74.21 pp
AQB: -9.83% · ABP: -84.04%
3M Horizon AQB +82.75 pp
AQB: -8.75% · ABP: -91.5%
6M Horizon AQB +71.81 pp
AQB: -18.68% · ABP: -90.49%
1Y Horizon AQB +71.81 pp
AQB: -18.68% · ABP: -90.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AQB vs ABP. Trailing 12-month operating profitability (AQB 0.0% vs ABP 0.0%) and valuation multiples (AQB N/M vs ABP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AQB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-68.9% · N/M
ABP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AQB BREAKDOWN
69d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AQB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AQB Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $9.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AQB vs ABP Key Questions & Quantitative Answers

As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Abpro Holdings, Inc (ABP) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.4/100 HOLD) after splitting the core matrix 4–1 (led by Growth & Scale), while ABP wins 3–1 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus ABP at $0.52 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. ABP 44.4/100 HOLD) and 0.93β · 117% Vol risk profile, whereas ABP leads top-line expansion (-100.0% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile ABP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AQB leads the Growth & Scale pillar: AQB posts -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABP at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, AQB generates N/A in USD-normalized revenue versus N/A for ABP. In operating R&D and SG&A reinvestment, AQB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABP.

AQB and ABP trade at balanced relative valuation multiples. AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas ABP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AQB (-68.9% ROE) versus ABP (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk). By comparison, ABP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.33β · 258% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.